Cresco Labs Announces US$38 Million in Non-Dilutive Funding, Mutually Terminates Its Proposed Acquisition Of VidaCann Ltd.
The company is eliminating ~$120 million in near-term cash requirements.
Published at Tue, 26 Nov 2019 18:31:00 GMT
